A centralized mailed program with stepped increases of support increases time in compliance with colorectal cancer screening guidelines over 5 years: A randomized trial

Cancer

Volumn 123, Issue 22, 2017, Pages 4472-4480

  Green, Beverly B ^a,b   Anderson, Melissa L ^a   Cook, Andrea J ^c   Chubak, Jessica ^a,c   Fuller, Sharon ^a   Meenan, Richard T ^d   Vernon, Sally W ^e  

^a KAISER PERMANENTE   (United States)

^b UNIVERSITY OF WASHINGTON SCHOOL OF MEDICINE   (United States)

^c UNIVERSITY OF WASHINGTON   (United States)

^d CENTER FOR HEALTH RESEARCH   (United States)

^e UNIVERSITY OF TEXAS SCHOOL OF PUBLIC HEALTH   (United States)

Author keywords

adherence; colorectal cancer; health services; prevention and control; screening

Indexed keywords

ADULT; AGED; ARTICLE; CANCER SCREENING; COLONOSCOPY; COLORECTAL CANCER; CONTROLLED STUDY; FEMALE; FOLLOW UP; HUMAN; MALE; MIDDLE AGED; MULTICENTER STUDY (TOPIC); OCCULT BLOOD TEST; PATIENT COMPLIANCE; POSTAL MAIL; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL (TOPIC); SIGMOIDOSCOPY; WASHINGTON; CLINICAL TRIAL; COLORECTAL TUMOR; EARLY CANCER DIAGNOSIS; MASS SCREENING; MULTICENTER STUDY; OCCULT BLOOD; PRACTICE GUIDELINE; PROCEDURES; RANDOMIZED CONTROLLED TRIAL; REMINDER SYSTEM; STANDARDS; STATISTICS AND NUMERICAL DATA; TELEPHONE; TIME FACTOR;

AGED; COLONOSCOPY; COLORECTAL NEOPLASMS; EARLY DETECTION OF CANCER; FEMALE; HUMANS; MALE; MASS SCREENING; MIDDLE AGED; OCCULT BLOOD; PATIENT COMPLIANCE; POSTAL SERVICE; PRACTICE GUIDELINES AS TOPIC; REMINDER SYSTEMS; TELEPHONE; TIME FACTORS;

EID: 85026360971     PISSN: 0008543X     EISSN: 10970142     Source Type: Journal    
DOI: 10.1002/cncr.30908     Document Type: Article

References (43)

1. Siegel RL, Miller KD, Jemal A. Cancer statistics, 2017. CA Cancer J Clin. 2017;67:7-30.
2. Vogelaar I, van Ballegooijen M, Schrag D, et al. How much can current interventions reduce colorectal cancer mortality in the U.S.? Mortality projections for scenarios of risk-factor modification, screening, and treatment. Cancer. 2006;107:1624-1633.
3. Baker DW, Brown T, Buchanan DR, et al Comparative effectiveness of a multifaceted intervention to improve adherence to annual colorectal cancer screening in community health centers: a randomized clinical trial. JAMA Intern Med. 2014;174:1235-1241.
4. Church TR, Yeazel MW, Jones RM, et al. A randomized trial of direct mailing of fecal occult blood tests to increase colorectal cancer screening. J Natl Cancer Inst. 2004;96:770-780.
5. Coronado GD, Golovaty I, Longton G, Levy L, Jimenez R. Effectiveness of a clinic-based colorectal cancer screening promotion program for underserved Hispanics. Cancer. 2011;117:1745-1754.
6. Freedman JD, Mitchell CK. A simple strategy to improve patient adherence to outpatient fecal occult blood testing. J Gen Intern Med. 1994;9:462-464.
7. Goldman SN, Liss DT, Brown T, et al. Comparative effectiveness of multifaceted outreach to initiate colorectal cancer screening in community health centers: a randomized controlled trial. J Gen Intern Med. 2015;30:1178-1184.
8. Hoffman RM, Steel SR, Yee EF, et al. A system-based intervention to improve colorectal cancer screening uptake. Am J Manag Care. 2011;17:49-55.
9. Levy BT, Xu Y, Daly JM, Ely JW. A randomized controlled trial to improve colon cancer screening in rural family medicine: an Iowa Research Network (IRENE) study. J Am Board Fam Med. 2013;26:486-497.
10. Miller MF, Wong JG. Reducing financial barriers enhances the return rate of stool Hemoccult packets. Am J Med Sci. 1993;306:98-100.
11. Singal AG, Gupta S, Tiro JA, et al. Outreach invitations for FIT and colonoscopy improve colorectal cancer screening rates: a randomized controlled trial in a safety-net health system. Cancer. 2016;122:456-463.
12. Kapidzic A, Grobbee EJ, Hol L, et al. Attendance and yield over three rounds of population-based fecal immunochemical test screening. Am J Gastroenterol. 2014;109:157-164.
13. Levin TR, Jamieson L, Burley DA, Reyes J, Oehrli M, Caldwell C. Organized colorectal cancer screening in integrated health care systems. Epidemiol Rev. 2011;33:101-110.
14. Steele RJ, McClements PL, Libby G, Carey FA, Fraser CG. Patterns of update in a biennial faecal occult blood test screening programme for colorectal cancer. Colorectal Dis. 2014;16:28-32.
15. van der Vlugt M, Grobbee EJ, Bossuyt PM, et al. Adherence to colorectal cancer screening: four rounds of faecal immunochemical test-based screening. Br J Cancer. 2017;116:44-49.
16. ClinicalTrials.gov. Systems of Support (SOS) to Increase Colon Cancer Screening and Follow-Up (SOS). https://clinicaltrials.gov/ct2/show/NCT00697047. Accessed December 12, 2016.
17. Green BB, Wang CY, Anderson ML, et al. An automated intervention with stepped increases in support to increase uptake of colorectal cancer screening: a randomized trial. Ann Intern Med. 2013;158:301-311.
18. ClinicalTrials.gov. Systems of Support (SOS) to Increase Colon Cancer Screening and Follow-Up. https://www.clinicaltrials.gov/ct2/show/NCT00697047?term=systems+of+support&rank=1. Accessed March 15, 2017.
19. Green BB, Wang CY, Horner K, et al. Systems of Support to Increase Colorectal Cancer Screening and Follow-Up Rates (SOS): design, challenges, and baseline characteristics of trial participants. Contemp Clin Trials. 2010;31:589-603.
20. Green BB, Bogart A, Chubak J, et al. Nonparticipation in population-based trial to increase colorectal cancer screening. Am J Prev Med. 2012;42:390-397.
21. US Preventive Services Task Force. Colorectal cancer: screening. http://www.uspreventiveservicestaskforce.org/uspstf/uspscolo.htm. Published October 2008. Accessed December 12, 2016.
22. Green BB, Anderson ML, Chubak J, et al. Colorectal cancer screening rates increased after exposure to the patient-centered medical home (PCMH). J Am Board Fam Med. 2016;29:191-200.
23. Green BB, Anderson ML, Chubak J, Fuller S, Meenan RT, Vernon SW. Impact of continued mailed fecal tests in the patient-centered medical home: year 3 of the Systems of Support to Increase Colon Cancer Screening and Follow-Up randomized trial. Cancer. 2016;122:312-321.
24. Quintero E, Castells A, Bujanda L, et al. Colonoscopy versus fecal immunochemical testing in colorectal-cancer screening. N Engl J Med. 2012;366:697-706.
25. ClinicalTrials.gov. Colonoscopy Versus Fecal Immunochemical Test in Reducing Mortality From Colorectal Cancer (CONFIRM). https://clinicaltrials.gov/ct2/show/NCT01239082. Accessed July 14, 2017.
26. ClinicalTrials.gov. Colonoscopy and FIT as Colorectal Cancer Screening Test in the Average Risk Population. https://clinicaltrials.gov/ct2/show/NCT02078804?term=screesco&rank=1. Accessed December 12, 2016.
27. Inadomi JM, Vijan S, Janz NK, et al. Adherence to colorectal cancer screening: a randomized clinical trial of competing strategies. Arch Intern Med. 2012;172:575-582.
28. Gupta S, Halm EA, Rockey DC, et al. Comparative effectiveness of fecal immunochemical test outreach, colonoscopy outreach, and usual care for boosting colorectal cancer screening among the underserved: a randomized clinical trial. JAMA Intern Med. 2013;173:1725-1732.
29. Centers for Disease Control and Prevention. Vital signs: colorectal cancer screening test use—United States, 2012. MMWR Morb Mortal Wkly Rep. 2013;62:881-888.
30. Robertson DJ, Lee JK, Boland CR, et al. Recommendations on fecal immunochemical testing to screen for colorectal neoplasia: a consensus statement by the US Multi-Society Task Force on Colorectal Cancer. Gastroenterology. 2017;152:1217-1237.e3.
31. Shaukat A, Mongin SJ, Geisser MS, et al. Long-term mortality after screening for colorectal cancer. N Engl J Med. 2013;369:1106-1114.
32. Thomas W, White CM, Mah J, Geisser MS, Church TR, Mandel JS. Longitudinal compliance with annual screening for fecal occult blood. Minnesota Colon Cancer Control Study. Am J Epidemiol. 1995;142:176-182.
33. Jensen CD, Corley DA, Quinn VP, et al. Fecal immunochemical test program performance over 4 rounds of annual screening: a retrospective cohort study. Ann Intern Med. 2016;164:456-463.
34. Bretthauer M, Kaminski MF, Loberg M, et al; Nordic-European Initiative on Colorectal Cancer (NordICC) Study Group. Population-based colonoscopy screening for colorectal cancer: a randomized clinical trial. JAMA Intern Med. 2016;176:894-902.
35. Mehta SJ, Jensen CD, Quinn VP, et al. Race/ethnicity and adoption of a population health management approach to colorectal cancer screening in a community-based healthcare system. J Gen Intern Med. 2016;31:1323-1330.
36. White A, Thompson TD, White MC, et al. Cancer screening test use—United States, 2015. MMWR Morb Mortal Wkly Rep. 2017;66:201-206.
37. Knudsen AB, Zauber AG, Rutter CM, et al. Estimation of benefits, burden, and harms of colorectal cancer screening strategies: modeling study for the US Preventive Services Task Force. JAMA. 2016;315:2595-2609.
38. Holden DJ, Harris R, Porterfield DS, et al. Enhancing the use and quality of colorectal cancer screening. Evid Rep Technol Assess (Full Rep). 2010;190:1-195.
39. The Community Guide. Cancer. https://www.thecommunityguide.org/topic/cancer. Accessed December 12, 2016.
40. National Cancer Institute. Colorectal cancer screening intervention programs. https://rtips.cancer.gov/rtips/topicPrograms.do?topicId=102265&choice=default. Accessed December 12, 2016.
41. Winawer SJ, Fischer SE, Levin B. Evidence-based, reality-driven colorectal cancer screening guidelines: the critical relationship of adherence to effectiveness. JAMA. 2016;315:2065-2066.
42. Meenan RT, Anderson ML, Chubak J, et al. An economic evaluation of colorectal cancer screening in primary care practice. Am J Prev Med. 2015;48:714-721.
43. Chubak J, Hubbard R. Defining and measuring adherence to cancer screening. J Med Screen. 2016;23:179-185.